OpenAI acquires startup Orchestra Bio to beef up its biotech business
OpenAI has acquired Orchestra Bio to strengthen its biotech capabilities and integrate the startup's team and technology into Rosalind, its AI model for life sciences research. The acquisition will enhance Rosalind Workbench, a tool designed to assist researchers in experiment planning and data analysis.
Source: TechCrunch